31.07
전일 마감가:
$29.30
열려 있는:
$29.39
하루 거래량:
1.91M
Relative Volume:
1.58
시가총액:
$1.86B
수익:
$277.49M
순이익/손실:
$-192.14M
주가수익비율:
-9.2455
EPS:
-3.36
순현금흐름:
$-95.52M
1주 성능:
+9.93%
1개월 성능:
-20.83%
6개월 성능:
-38.24%
1년 성능:
-25.86%
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TWST
Twist Bioscience Corp
|
31.07 | 1.76B | 277.49M | -192.14M | -95.52M | -3.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
396.47 | 152.34B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.23 | 135.39B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
514.80 | 41.54B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
111.05 | 31.59B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
139.10 | 24.31B | 15.50B | 1.33B | 2.16B | 7.34 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-13 | 개시 | Wolfe Research | Outperform |
2024-06-04 | 개시 | Guggenheim | Buy |
2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
2023-09-27 | 개시 | Berenberg | Buy |
2023-01-05 | 개시 | Scotiabank | Sector Outperform |
2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
2022-03-02 | 재개 | Cowen | Outperform |
2021-10-15 | 재개 | Cowen | Outperform |
2021-06-29 | 개시 | William Blair | Outperform |
2021-06-04 | 개시 | Goldman | Neutral |
2021-04-12 | 개시 | Piper Sandler | Overweight |
2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
2019-05-31 | 개시 | Evercore ISI | Outperform |
2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Cetera Investment Advisers Invests $220,000 in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Gap Down to $28.2 on May 28 - GuruFocus
Twist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLC - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DE - Defense World
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Ameriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 5.14% on May 21 - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Bioscie - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Biosciences | TWST Stock News - GuruFocus
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions - Business Wire
Twist Bioscience stock hits 52-week low at $28.41 By Investing.com - Investing.com Canada
Twist Bioscience stock hits 52-week low at $28.41 - Investing.com
Twist Bioscience Corp (TWST) Stock Price Down 3.12% on May 19 - GuruFocus
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $50.40 - Defense World
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference - 01net
DNA Synthesis Market to Witness Growth from Synthetic Biology - openPR.com
Stifel Financial Corp Purchases 1,364 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience - Investing.com Nigeria
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience By Investing.com - Investing.com South Africa
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Leerink Partnrs Cuts Earnings Estimates for Twist Bioscience - Defense World
William Blair Issues Optimistic Outlook for TWST Earnings - Defense World
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
The Goldman Sachs Group Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Cathie Wood’s ARK Makes Bold Tuesday Moves with Key Stock Swaps - Wall Street Pit
Twist Bioscience (NASDAQ:TWST) Reaches New 52-Week Low After Earnings Miss - Defense World
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | - GuruFocus
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):